Your browser doesn't support javascript.
loading
Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic Program.
Gencel-Augusto, Jovanka; Su, Xiaoping; Qi, Yuan; Whitley, Elizabeth M; Pant, Vinod; Xiong, Shunbin; Shah, Vrutant; Lin, Jerome; Perez, Encarnacion; Fiorotto, Marta L; Mahmud, Iqbal; Jain, Abhinav K; Lorenzi, Philip L; Navin, Nicholas E; Richie, Ellen R; Lozano, Guillermina.
Affiliation
  • Gencel-Augusto J; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas.
  • Su X; Department of Genetics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Qi Y; Department of Bioinformatics and Computational Biology, MDACC, Houston, Texas.
  • Whitley EM; Department of Bioinformatics and Computational Biology, MDACC, Houston, Texas.
  • Pant V; Department of Veterinary Medicine and Surgery, MDACC, Houston, Texas.
  • Xiong S; Department of Genetics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Shah V; Department of Genetics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Lin J; Department of Genetics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Perez E; Department of Genetics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.
  • Fiorotto ML; Department of Epigenetics and Molecular Carcinogenesis, MDACC, Houston, Texas.
  • Mahmud I; United States Department of Agriculture/Agricultural Research Service Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Jain AK; Department of Bioinformatics and Computational Biology, MDACC, Houston, Texas.
  • Lorenzi PL; Metabolomics Core Facility, MDACC, Houston, Texas.
  • Navin NE; Department of Epigenetics and Molecular Carcinogenesis, MDACC, Houston, Texas.
  • Richie ER; Department of Bioinformatics and Computational Biology, MDACC, Houston, Texas.
  • Lozano G; Metabolomics Core Facility, MDACC, Houston, Texas.
Cancer Discov ; 13(5): 1230-1249, 2023 05 04.
Article in En | MEDLINE | ID: mdl-37067911

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Li-Fraumeni Syndrome Type of study: Risk_factors_studies Limits: Animals Language: En Journal: Cancer Discov Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Li-Fraumeni Syndrome Type of study: Risk_factors_studies Limits: Animals Language: En Journal: Cancer Discov Year: 2023 Document type: Article Country of publication: